Jolted by US ban, Indian regulators wake up to review Ranbaxy units

DRUG Controller General of India (DCGI) inspectors are set to inspect pharma giant  Ranbaxy’s Toansa unit in Punjab this week, days after the US Food and Drug Administration banned import of products made there for manufacturing violations.

Read Full Story>>